Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-04-22
1979-01-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
RE0298921
ABSTRACT:
The dopamine content in brain tissue of animals is increased by administering to the animal L-dopa or its salts in combination with L-.alpha.-hydrazino-.alpha.-lower alkyl-3,4-dihydroxyphenyl propionic acid or its salts [or .alpha.-hydrazino-3,4-dihydroxyphenyl propionic acid or its salts]. The increased dopamine content in brain tissue tends to alleviate some of the symptoms caused by Parkinsonism and similar diseases.
REFERENCES:
patent: 3322630 (1967-05-01), Porter
patent: 3462536 (1969-08-01), Chemerda et al.
patent: 3557292 (1971-01-01), Bartholini
patent: 3830827 (1974-08-01), Karady et al.
Bartholini et al., Nature, vol. 215, Aug. 19, 1967, pp. 852-853.
Udenfriend et al., Mol. Pharmacol. 2, 95-105, (1966).
Eidelberg et al., Int. J. Neuropharmacol., 1966, 5, 59-74.
Chem. Abst. 58-705H (1963); 59-12921c (1963); 65-96006 (1965) and 66-26274e (1967).
Chase et al., Neurol., 22 (4), 384, Apr. 1972.
Mars, Arch. Neurol. 28, 93, Feb. 1973.
"Treatment of Parkinsonism - The Role of DOPA Decarboxylase Inhibitors" in Advanced Neurology, 2, pp. 82, 83, 88, 89, 166, 167, 168, 169, 268 & 269, (M. Yahr. ed. (1973).
Porter et al., Biochem. Pharmacol. II, 1067, (1962).
Sletzenger et al., J. Med. Chem. 6, 101, (Mar. 1963).
Ropp et al., Brain Res., 2 (4), 323 (1966).
Cotzias, "L-DOPA in Parkinson's Disease", Hospital Practice, Sep. 1969 at 35.
Cotzias et al., New Eng. J. Med. 280, 337, (Feb. 13, 1969).
Bartholini et al., Helv. Physiol. Acta., 25 CR170, (1967).
Henning, Brit. J. Pharmacol. 34, 233P, Sep. 1968.
Bruinvels et al., European J. Pharmacol., 4, 31 (1968).
Friedman Stanley J.
Merck & Co. , Inc.
LandOfFree
Composition and method of treating dopamine deficiency in brain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method of treating dopamine deficiency in brain , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method of treating dopamine deficiency in brain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143621